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Abstract 
Benign proliferative diseases of the uterus, which 
include uterine myoma and endometriosis occupy a 
leading place in the structure of gynecological 
diseases. The objective of the research was a 
bioinformatic study of the involvement of candidate 
genes in the formation of a combination of 
endometriosis with uterine myoma in women. As a 
result of the study, 5 molecular-genetic markers were 
genotyped in 109 patients with a combination of 
endometriosis with uterine myoma and 981 women 
of the control group. It has been established that the 
combinations of molecular genetic markers 
rs466639 with rs713586 and rs10441737 (OR = 
2.45) and rs466639 with rs3756261, rs713586 and 
rs10980926 (OR = 1.36) are risk factors for the 
development of a combination of endometriosis and 
uterine myoma among women of the Central region 
of Russia. 
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Introduction 
The relevance of benign proliferative diseases of the 
uterus, which include uterine myoma and 
endometriosis, is associated with a fairly high 
prevalence and comorbidity of these pathological 
conditions due to the common etiology and 
pathogenesis, which explains a similar in most cases 
clinical pattern. 
Endometriosis is a process when benign proliferation 
of tissue occurs outside the uterine cavity, similar to 
the endometrium in the morphological and 
functional properties [Bruner-Tran K.L. et al., 2013]. 
This disease occurs in 10% of women of 
reproductive age [Rahmioglu N. et al., 2015] and is 
one of the main causes of infertility, dysmenorrhea, 
dyspareunia, as well as chronic pelvic pain, adhesion 
of the pelvic organs, which together leads to a 
general deterioration quality of life of women 
[Truskinovsky A.M. et al., 2014; Ponomarenko I.V. 
et al., 2016]. 
Uterine myoma is one of the most common female 
genital benign tumors that occurs in 20-40% of 
women of reproductive age [Churnosov M.I. et al., 
2014; Taylor D.K. et al., 2015; Pachomov S.P. et al., 
2016]. Clinical manifestations of this disease are 
associated with uterine bleeding, pain, compression 
of adjacent organs, miscarriage [Commandeur A.E. 
et al., 2015; Krivoshei I.V. et al., 2015a]. As a 
consequence, uterine myoma becomes the main 
cause of hysterectomy in many countries of the 
world. 
Benign proliferative diseases of the uterus have a 
common pathogenesis and therefore often occur 
concomitantly. Thus, 27% of women with 
endometriosis have concomitant uterine myoma 
[Donato N.D. et al., 2014; Krivoshei I.V. et al., 2015 
b]. 
One of the factors predetermining the development 
of endometriosis and uterine myoma may be the age 
of menarche and associated candidate genes [Elks 
C.E. et al., 2010]. 
The objective of the study was a bioinformatic study 
of the involvement of candidate genes in the 
formation of a combination of endometriosis with 
uterine myoma in women. 
 
Materials and Methods 
 In this study, patients with a combination of 
endometriosis and uterine myoma (n=109) were 
selected from a group of 947 patients with various 
uterine hyperplastic processes. The sample was 
made on the basis of the gynecological department 
of the perinatal center of St. Joasaph Belgorod 
Regional Clinical Hospital. Patients with a 
combination of uterine myoma and endometriosis 
underwent a clinical, clinical and laboratory 
examination, ultrasound examination of pelvic 
organs, hysteroscopy followed by targeted 
diagnostic scraping of the uterine cavity and 
histological examination of scrapings. All patients 
signed an informed consent for inclusion in the study 
and use of the data obtained. The control group 
involved 981 women without proliferative diseases 
of the pelvic organs. 
All patients with endometriosis and uterine myoma 
were performed typing of 5 molecular-genetic 
markers rs466639 RXRG, rs713586 DNAJC27, 
rs10441737 ZNF483, rs10980926 ZNF483, 
rs3756261 EGF. The choice of these polymorphic 
markers for the study is due to their significant 
regulatory and expression potential (HaploReg 
(v.4.1.) (http://compbio.mit.edu/HaploReg)) and the 
important ethiopathogenetic significance of these 
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genes for hyperplastic uterine disease [Commandeur 
A.E. et al., 2015].  
As the material for the study we used 8-9 ml of 
venous blood taken from the cubital vein of a 
proband. A genomic DNA was isolated from 
peripheral blood by the method of phenol-
chloroform extraction [Miller S.A., 1988]. Analysis 
of the investigated loci was carried out by the method 
of polymerase chain reaction of DNA synthesis with 
the use of oligonucleotide primers and probes. 
Statistical processing of data was carried out using 
"STATISTICA forWindows 6.0" and 
"MicrosoftExcel 2007" software packages. To 
analyze the compliance of the observed distribution 
of genotypes with the expected one, based on Hardy-
Weinberg equilibrium, we used 2 test. 
A bioinformatic study was performed by APSampler 
[http://sources.redhat.com/cygwin/], operating 
Markov chain Monte Carlo, and Bayesian 
nonparametric statistics [Favorov A.V. et al., 2005]. 
Results and Discussion 
We examined 109 women with endometriosis and 
uterine myoma and 981 women of the control group. 
The main characteristics of the study and control 
groups are shown in Table 1. The control group is 
fully comparable with the sample of patients with a 
combination of endometriosis and uterine myoma by 
age, nationality and place of birth. 
An analysis of the distribution of studied 
polymorphic markers of candidate genes showed 
that for all the studied loci in the group of patients 
with uterine myoma and hyperplastic endometrium 
processes, as well as in the control sample, the 
empirical distribution of genotypes corresponds to 
the theoretically expected one at Hardy-Weinberg 
equilibrium (p>0.05). 
 
Table 1. Characteristics of the Subjects from the Case and Control Groups 
Characteristics Cases Controls 
Total 109 981 
Age, yrs  42.44±7.81 39.94±9.31 
Height, cm 1.66±0.07 1.65±0.06 
Weight, kg 75.11±13.41 69.69±12.49 
IMB 27.39±5.03 25.69±4.24 
 
A high risk of a combination of endometriosis with 
uterine myomas (OR = 2.39) in women is also 
determined by the combination of four genetic 
markers C rs466639 with A rs3756261 with T 
rs713586 with G rs10980926. The concentration of 
this combination among patients with endometriosis 
and uterine myoma (85.85%) is 1.20 times higher 
than that of the control group (71.77%, p=0.0008, 
pperm =0.0012, 95% CI 1.36-4.19). 
The online service HaploReg (v.4.1.) 
(http://compbio.mit.edu/HaploReg) was used to 
study the regulatory potential and the effect on gene 
expression of significant polymorphisms associated 
with endometriosis and uterine myoma. The genetic 
polymorphism rs466639, localized in the intron 
portion of the RXRG gene, is in the region of the 
enhancer of 10 types of tissues (including skeletal 
muscles in women, smooth muscles of a number of 
internal organs, adipose tissue, etc.). Moreover, the 
alternative allele C of this polymorphism 
significantly increases the affinity of the regulatory 
DNA motifs Foxa_disc3 (PWM=-12.0), GR_disc5 
(PWM=+12.0), YY1_known4 (PWM=+9.2). There 
are literature data (the results of GWAS studies) 
about the involvement of this locus in the formation 
of menarche age (р=1Е-13 and р=2Е-24) [Elks C.E. 
et al., 2010; Perry J.R., 2014].  
The genetic polymorphism rs713586, which is 8.5 
kb from the 3rd end of the DNAJC27 gene, has a 
high regulatory and expressive potential. The "risk" 
T allele of this locus increases the affinity of the 
three DNA motifs - Pbx3_disc3 (PWM=+0.5), 
SP2_disc2 (PWM=+5.2), TATA_disc1 
(PWM=+11.9) to regulatory influences. This 
polymorphic locus is associated with the expression 
level of the DNAJC27 genes (p=5.08E-11), ADCY3 
(p=1.61E-35), RP11-44B20.1 (p=7.17E-22) in blood 
cells, and the POMC gene in muscle tissue (p=1.4E-
05). According to the results of GWAS studies, the 
genetic polymorphism rs713586 is associated with 
the body mass index (p=6E-22) [Speliotes E.K. et al., 
2011]. 
The polymorphic locus rs10441737 of the ZNF483 
gene (intron region) is associated with the expression 
level of the ZNF483 gene in adipose tissue 
(p=1.94E-9) and has a significant regulatory 
potential as it makes part of 9 DNA motifs. It should 
be noted that the allele C of this locus increases the 
affinity of the Hox10 motifs (PWM=+2.0), Hoxb8 
(PWM=+2.9), Mef2_known4 (PWM=+11.1), Nux6-
2 (PWM=+0.6), while the alternative T allele is 
associated with high affinity of Fox motifs (PWM=-
10.6), Pou1+1_1 (PWM=-11.7), Pou2f2_known4 
(PWM=-5.4), Pou13+3 (PWM=-6.5), and Pou5 + 1 
- disc1 (PWM=-7.7). This polymorphism is also 
associated with the age of menarche (p=4E-15) 
[Demerath E.W. et al., 2013]. 
Another significant polymorphic locus of the gene 
ZNF483 - rs10980926 is also associated with the 
level of expression of the gene ZNF483 in adipose 
tissue (p=1.12E-0.6), KIAA0368 in the blood 
(p=1.75E-9) and is localized in 9 regulatory DNA 
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motifs. A allele is associated with increased affinity 
for the regulatory influences of the following motifs: 
Irf_known4 (PWM=+11.9), Nkx2_7 (PWM=-12.0), 
Nkx2_9 (PWM=+11.9), RXRA – disc3 
(PWM=+1.7). While the G allele alternative to it is 
connected with the increased affinity of motives AD-
1_known4 (PWM=-2.7), AFF3_disc1 (PWM=-7.7), 
BHLHE40_disc1 (PWM=-7.5), GATA_disc6 
(PWM=-11.7), Mxi1_known1 (PWM=-3.5), 
2EB1_known4 (PWM=-11.9), ZEB1_known5 
(PWM=-12.0). This genetic polymorphism is 
involved in the formation of menarche age (p=4E-
11) [Elks C.E. et al., 2010] and is associated with 
anthropometric characteristics at pubertal age 
(р=2Е-7) [CousminerD.L. et al., 2014]. 
The genetic polymorphism rs3756261, located in the 
region of 1.7 kb from the 5th end of the gene EGF, 
marks the regulatory DNA motif Obox3. With the 
increased affinity of this motive, the A allele 
(PWM=+ 2.5) is associated with regulatory 
influences. EGFplays a key role in such processes as 
proliferation, differentiation of different cell types, 
oncogenesis [Yarom N. et al., 2011; Lien G.S. et al., 
2014]. It should be noted that overexpression of EGF 
correlates with an increase in the likelihood of 
metastatic development [Chang W.C. et al., 2015]. 
 
Summary 
Thus, the results of the study allow us to conclude 
that the combinations of molecular genetic markers 
rs466639 with rs713586 and rs10441737 (OR = 
2.45) and rs466639 with rs3756261, rs713586 and 
rs10980926 (OR = 1.36) are risk factors for the 
development of a combination of endometriosis and 
uterine myoma among women of the Central region 
of Russia. 
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